drug
EPOPROSTENOL SODIUM
Marketedupdated 5mo agoby Janssen-Cilag Holdings Inc (Inactive)
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 2, 2027
125 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Mar 15, 2027formulationUS 8318802166d
- Mar 15, 2027formulationUS 8318802166d
- Feb 2, 2027patentUS 8598227125d
- Feb 2, 2027patentUS 8598227125d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that